Navigation Links
YM BioSciences Reports Fiscal First Quarter 2011 Operational and Financial Results
Date:11/11/2010

ew product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that nimotuzumab will continue to demonstrate a competitive safety profile in ongoing and future clinical trials; that our JAK1/JAK2 inhibitor CYT387 and our VDA small molecule CYT997 will generate positive efficacy and safety data in future clinical trials; that YM and its various partners will complete their respective clinical trials within the timelines communicated in this release. Except as required by applicable securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Summary financial statements attached:YM BIOSCIENCES INC.
Interim Consolidated Balance Sheets
(Expressed in Canadian dollars, unless otherwise noted) September 30,  June 30, 2010 2010 (Unaudited)   Assets Current assets:   Cash and cash equivalents
$  15,095,919 $
9,460,141   Short-term deposits
25,073,158
26,184,991   Accounts receivable
,007
,184   Prepaid expenses
24,428
237,962 40,459,512
46,044,278 Property and equipment
28,855
84,775 Intangible asset
,518,7
,645,714 $
51,107,077 $
57,774,767 Liabilities and Shareholders' Equity Current liabilities:   Accounts payable
$ 693,188 $
99,277   Accrued liabilities
2,729,655
2,085,824   Deferred revenue
594,072
,523,916 4,016,915
4,309,017 Deferred revenue
2,277,27
,650,909 Shareholders' equity:   Share capital
203,522,4
'/>"/>
SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. YM BIOSCIENCES REPORTS SIGNIFICANT RESPONSE RATES IN ANEMIA, SPLENOMEGALY, AND CONSTITUTIONAL SYMPTOMS FROM THE PHASE I/II TRIAL OF ITS JAK1/JAK2 INHIBITOR, CYT387, IN MYELOFIBROSIS
2. Regado Biosciences Awarded Three Grants from the Federal Government to Advance Research of Lead Programs
3. Sangamo BioSciences Awarded Grants for the Development of Four ZFP Therapeutic® Programs
4. Ardea Biosciences Awarded a $733,438 Grant from the U.S. Government Under the Patient Protection and Affordable Care Act
5. X-BODY BioSciences Awarded Grant for Therapeutic Discovery Project Targeting Metastatic Tumor Stem Cells
6. Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
7. Regado Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference in New York City
8. GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500â„¢
9. Sangamo BioSciences Announces Third Quarter 2010 Conference Call and Webcast
10. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
11. Cell Biosciences to Acquire Convergent Bioscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Texas (PRWEB) December 23, 2014 ... methyl mercaptan such as its definition, classification, ... presents product specification, manufacturing process, and product ... technology and applications. The analysis also covers ... marketing channels, industry development trend and proposals. ...
(Date:12/24/2014)... Pipette.com announces their Holiday in ... submit their #HolidayInTheLab pictures for a chance to win ... For those struggling to think of a holiday gift ... the Lab Contest provides the ideal holiday presents. The ... send pictures of their chemistree, holiday sweaters, as well ...
(Date:12/24/2014)... -- PharmaBoardroom,s new report, , Healthcare ... for free download , digs deep into this vibrant ... the sector today. One area where ... developing a homegrown pharmaceutical manufacturing base, even if the government,s ... way off. A cursory comparison with neighboring Morocco ...
(Date:12/24/2014)... and NEW YORK , Dec. 23, ... open-label pilot study of mazindol in children with attention ... Therapy in December 2014 . The ... children with attention deficit/hyperactivity disorder" ( Konofal et al, ... Dec 1;8:2321-2332. eCollection 2014 ) shows that mazindol ...
Breaking Biology Technology:Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3
... mir Vana miRNA Detection Kit ... Sensitive -- Detect miRNA or siRNA in as little as 10 ng total RNA , ... or washing conditions , ... to membrane for hybridization , Multiple target detection ...
... , ... array analysis have found that a combination of phenol based , ... array data than ... of RiboPure RNA Isolation Kits are the first kits that combine , ...
... Dicer and Escherichia coli RNase ... vitro to cleave long dsRNA, producing siRNA cocktails that are , ... endoribonuclease that contains RNase III domains ... enzyme responsible for cleavage of long dsRNAs to siRNA in the , ...
Cached Biology Technology:Detecting Attomole Amounts of Small RNA 2Detecting Attomole Amounts of Small RNA 3Improve RNA Isolation for Array Analysis and More 2Improve RNA Isolation for Array Analysis and More 3Improve RNA Isolation for Array Analysis and More 4Improve RNA Isolation for Array Analysis and More 5Improve RNA Isolation for Array Analysis and More 6Dicer vs. RNase III for Preparation of siRNA Cocktails 2Dicer vs. RNase III for Preparation of siRNA Cocktails 3
(Date:12/11/2014)... -- That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ... best ways to treat it. For example, a ...
(Date:12/10/2014)... DIEGO , Dec. 9, 2014 CIE ... collaboration catalyst that provides the connective tissue that enhances ... enabling them to easily share client-level information; earned a ... to expand to organizations serving seniors aging in community ... Diego" partner on December 11 th 4-6p. ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... in the University of Pennsylvania,s Department of History and Sociology ... of conservation of large, charismatic wildlife, such as tigers, grizzly ... he consciously chose to investigate a creature that may be ... to write about something a bit closer to home, about ...
... from the Department of Energy,s Pacific Northwest National Laboratory ... 2013 American Geophysical Union Fall Meeting, which runs Monday, ... Convention Center in San Francisco. Among the noteworthy PNNL ... empty shale reservoirs, water needs for future energy production ...
... from the U.S. Department of Energy,s Argonne National Laboratory ... Greater Chicago (MWRD) to find out the typical sources ... For the MWRD-sponsored project, Argonne scientists will analyze samples ... season between March and November and run ...
Cached Biology News:Penn researcher traces the history of the American urban squirrel 2Penn researcher traces the history of the American urban squirrel 3At AGU: Shale sequestration, water for energy & soil microbes 2At AGU: Shale sequestration, water for energy & soil microbes 3Argonne partners with Metropolitan Water Reclamation District to study Chicago River microbe population 2
... powerful technology platform that automates gel processing ... quality sample preparation can be carried out ... is a powerful technology platform that automates ... It combines the functions of high-resolution gel ...
... Acquire images with any of UVP's ... load the Doc-It 1D Analysis software onto ... many image analysis functions and enhancement tools. ... and band finding algorithms for quick and ...
... Thermo IEC Microtube Rotor is TWO ROTORS ... change rotors. You can spin both ... tubes. Exclusive polypropylene rotor design provides excellent ... Polypropylene rotors are fully compatible with ...
Multidrop Micro high speed 1 l bulk reagent dispenser rapidly, precisely and accurately dispenses microvolumes of 1-50 l into 384- and 96-well microplates....
Biology Products: